Greedy Insider · Filing
LYEL · Buy · ARCH Venture Fund XIII, L.P.
ARCH Venture Fund XIII, L.P. (10% owner) bought 2,321,262 shares of Lyell Immunopharma, Inc. (LYEL) at $10.77, about $25M, on Nov 4, 2026, filed with the SEC on Nov 5, 2026.
Greediness Score 62 · Moderate · high confidence. Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0001012975-26-001013